Gastro
1 – 50 of 125
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Real-World Outcomes of Patients Starting Intravenous and Transitioning to Subcutaneous Vedolizumab in Inflammatory Bowel Disease
2024) In Digestive Diseases and Sciences(
- Contribution to journal › Article
-
Mark
Hyaluronic Acid-Conjugated Thermoresponsive Polymer-Based Bioformulation Enhanced Wound Healing and Gut Barrier Repair of a TNBS-Induced Colitis Injury Ex Vivo Model in a Dynamic Perfusion Device
(
- Contribution to journal › Article
- 2023
-
Mark
Impact on follow-up strategies in patients with primary sclerosing cholangitis
(
- Contribution to journal › Article
-
Mark
Alkaline sphingomyelinase (NPP7) impacts the homeostasis of intestinal T lymphocyte populations
(
- Contribution to journal › Article
-
Mark
Emergency subtotal colectomy rates in relation to anti-TNF therapy in inflammatory bowel disease patients : comparison of retrospective cohorts
(
- Contribution to journal › Article
- 2022
-
Mark
Response to : Response to: Irritable bowel syndrome symptoms in axial spondyloarthritis more common than among healthy controls: Is it an overlooked comorbidity?' by Proft et al.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
A novel food-based negative oral contrast agent compared with two conventional oral contrast agents in abdominal CT : a three-arm parallel blinded randomised controlled single-centre trial
(
- Contribution to journal › Article
-
Mark
Gut dysbiosis associated with worse disease activity and physical function in axial spondyloarthritis
(
- Contribution to journal › Article
-
Mark
Editorial: intravenous to subcutaneous vedolizumab—switch without glitch! Authors' reply
2022) In Alimentary Pharmacology and Therapeutics(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Letter: to switch or not to switch, that is the question—author's reply
(
- Contribution to journal › Letter
-
Mark
Real-world data on switching from intravenous to subcutaneous vedolizumab treatment in patients with inflammatory bowel disease
(
- Contribution to journal › Article
-
Mark
Histological remission in inflammatory bowel disease and risk of adverse pregnancy outcomes : A nationwide study
(
- Contribution to journal › Article
-
Mark
Leverns Funktioner. : Ett metabolt, biologiskt och kliniskt perspektiv
2022)(
- Book/Report › Book
- 2021
-
Mark
Lung Mast Cells Have a High Constitutive Expression of Carboxypeptidase A3 mRNA That Is Independent from Granule-Stored CPA3
(
- Contribution to journal › Article
-
Mark
Digestion and Absorption of Milk phospholipids in newborn and adults
(
- Contribution to journal › Scientific review
- 2020
-
Mark
Irritable bowel syndrome symptoms in axial spondyloarthritis more common than among healthy controls : Is it an overlooked comorbidity?
(
- Contribution to journal › Letter
-
Mark
Extrapancreatic infections are common in acute pancreatitis and they are related to organ failure : a population-based study
(
- Contribution to journal › Article
-
Mark
Mycophenolate mofetil for systemic sclerosis : Drug exposure exhibits considerable inter-individual variation-a prospective, observational study
(
- Contribution to journal › Article
-
Mark
Short and long-term efficacy of adalimumab in ulcerative colitis : a real-life study
(
- Contribution to journal › Article
-
Mark
Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis
(
- Contribution to journal › Article
- 2019
-
Mark
Pancreatic and mucosal enzymes in choline phospholipid digestion
(
- Contribution to journal › Article
-
Mark
Exocrine pancreatic function is preserved in systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Elevated faecal calprotectin is linked to worse disease status in axial spondyloarthritis : Results from the SPARTAKUS cohort
(
- Contribution to journal › Article
-
Mark
Liver cirrhosis in southern Sweden. Epidemiology and clinical course.
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Alkaliskt sfingomyelinas, en antiinflamatorisk faktor som kan motverka colit och colorektal cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
The Cost-effectiveness of Biological Therapy Cycles in the Management of Crohn's Disease
(
- Contribution to journal › Article
-
Mark
Risk and outcome of hepatocellular carcinoma in liver cirrhosis in Southern Sweden : a population-based study
(
- Contribution to journal › Article
-
Mark
Är ägg bra vid typ 2 diabetes, fetma och fettlever?
2019)(
- Other contribution › Web publication
-
Mark
Validation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis
(
- Contribution to journal › Article
-
Mark
Clinical course and mortality by etiology of liver cirrhosis in Sweden : a population based, long-term follow-up study of 1317 patients
(
- Contribution to journal › Article
-
Mark
Kolinfosfolipider, en nyttig kostkomponent vid alkoholfettler, NAFLD och NASH
2019)(
- Contribution to conference › Poster
- 2018
-
Mark
Deficiency of alkaline SMase enhances dextran sulfate sodium-induced colitis in mice with upregulation of autotaxin
(
- Contribution to journal › Article
-
Mark
Patients with liver cirrhosis show worse survival if decompensation occurs later during course of disease than at diagnosis
(
- Contribution to journal › Article
-
Mark
Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease
(
- Contribution to journal › Article
-
Mark
Alkaline sphingomyelinase (NPP7) in hepatobiliary diseases : A field that needs to be closely studied
(
- Contribution to journal › Scientific review
-
Mark
Serum Osteopontin Is Associated with Organ Failure in Patients with Acute Pancreatitis
(
- Contribution to journal › Letter
-
Mark
Nutrition vid leversjukdom
(
- Contribution to specialist publication or newspaper › Specialist publication article
- 2017
-
Mark
Emergency readmission following acute upper gastrointestinal bleeding
(
- Contribution to journal › Article
-
Mark
Long-term outcome of infliximab treatment in chronic active ulcerative colitis : a Swedish multicentre study of 250 patients
(
- Contribution to journal › Article
-
Mark
Severe intestinal dysbiosis is prevalent in primary Sjögren's syndrome and is associated with systemic disease activity.
(
- Contribution to journal › Article
-
Mark
Acute pancreatitis. Epidemiological aspects and prognosis.
2017)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Acute Pancreatitis : Impact of Alcohol Consumption and Seasonal Factors
(
- Contribution to journal › Article
-
Mark
Preoperative Aspartate Aminotransferase-to-Platelet Ratio Index Predicts Perioperative Liver-Related Complications Following Liver Resection for Colorectal Cancer Metastases
(
- Contribution to journal › Article
-
Mark
Long-term effectiveness of vedolizumab in inflammatory bowel disease : a national study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG)
(
- Contribution to journal › Article
-
Mark
Epidemiology and causes of death in a Swedish cohort of patients with autoimmune hepatitis
(
- Contribution to journal › Article
-
Mark
Mjölk och hälsa - färdigmjölkat i kothortstallet?
2017)(
- Other contribution › Web publication
- 2016
-
Mark
The role of bacterial infections in liver cirrhosis
2016)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Microproteinuria Predicts Organ Failure in Patients Presenting with Acute Pancreatitis
(
- Contribution to journal › Article
-
Mark
Incidence, clinical presentation and mortality of liver cirrhosis in Southern Sweden : A 10-year population-based study
(
- Contribution to journal › Article
-
Mark
All-cause mortality after ERCP
(
- Contribution to journal › Article